Researchers Investigate Possible Association of Inflammatory Markers and NSAIDs With CRC

Researchers investigated whether plasma inflammatory markers were linked to a risk of colorectal cancer and whether the use of anti-inflammatory drugs was differentially linked to risk of CRC according to baseline levels of inflammatory markers, according to a study published in Gastroenterology.

After collecting blood samples from more than 32,000 women, results showed plasma levels of the sTNFR-2, not CRP or IL-6, were linked to an increased risk of CRC. Anti-inflammatory drugs seem to reduce the risk of CRC in women with high, not low, baseline levels of sTNFR-2.

Read the study about the roles of inflammatory markers and NSAIDs in CRC.

Read other coverage about colorectal cancer:

– Researchers Revisit Surveillance Colonoscopy Utilization

– Coding for Screening Colonoscopy When There is Rectal Bleeding: Q&A With Paul Cadorette of mdStrategies

– 4 Steps to Increase Screening Colonoscopy Cases

Next Up in GI & Endoscopy